Tarceva Trial Proves Positive, Pushes OSI, Genentech Stocks April 27, 2004 By Aaron Lorenzo Investors adored results from a Phase III trial of an experimental cancer drug, significantly driving up stock prices of two of the companies involved in its development. (BioWorld Today)Read More
